Detalhe da pesquisa
1.
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Blood
; 137(22): 3093-3104, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598693
2.
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Blood
; 136(26): 3041-3050, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367545
3.
NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia.
Blood
; 134(4): 383-388, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31186273
4.
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group.
Blood
; 134(19): 1608-1618, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554635
5.
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Blood
; 133(8): 840-851, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563875
6.
The urine light chain/glomerular filtration rate (GFR) quotient shows a high sensitivity and specificity to detect cast nephropathy in monoclonal light chain disease.
Eur J Haematol
; 106(6): 836-841, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725381
7.
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.
Blood
; 132(16): 1703-1713, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190321
8.
Genomic Classification and Prognosis in Acute Myeloid Leukemia.
N Engl J Med
; 374(23): 2209-2221, 2016 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27276561
9.
Low-dose azacitidine, pioglitazone and all-trans retinoic acid is safe in patients aged ≥60 years with acute myeloid leukemia refractory to standard induction chemotherapy (AMLSG 26-16/AML-ViVA): results of the safety run-in phase.
Haematologica
; 109(4): 1274-1278, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37881883
10.
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17-10 CIARA trial).
Br J Haematol
; 183(2): 235-241, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30378121
11.
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia.
Haematologica
; 102(12): 2039-2047, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28971903
12.
Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation.
Blood
; 124(23): 3441-9, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25270908
13.
Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.
Blood
; 123(26): 4027-36, 2014 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797300
14.
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.
Blood
; 123(21): 3247-54, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652989
15.
Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin.
Haematologica
; 106(11): 2986-2989, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047179
16.
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG.
Blood
; 122(7): 1266-70, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23821658
17.
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.
Blood
; 122(1): 100-8, 2013 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23704090
18.
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.
Blood
; 121(16): 3284-8, 2013 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23435461
19.
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
Blood
; 121(1): 170-7, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23115274
20.
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
Blood
; 121(2): 385-91, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23160462